Kyoung Joon Oh

Kyoung Joon Oh serves as Associate Professor in the Department of Biochemistry and Molecular Biology at Rosalind Franklin University's Chicago Medical School and School of Graduate and Postdoctoral Studies. He leads research at the Center for Proteomics and Molecular Therapeutics, focusing on the structural mechanisms of apoptosis regulation.

Dr. Oh's research interests center on apoptosis mechanisms, particularly the role of BCL-2 family proteins in mitochondrial membrane permeabilization. His laboratory employs site-directed spin labeling EPR spectroscopy to investigate conformational changes in BAK and other pore-forming proteins during apoptotic signaling. Key research areas include:

• Molecular architecture of mitochondrial apoptotic pores
• BAK homodimer oligomerization mechanisms
• Structural dynamics of membrane-inserted BCL-2 proteins
• Identification of therapeutic targets for cancer and neurodegenerative diseases

His recent publications (2019-2024) demonstrate continued focus on BAK pore structure using advanced biophysical techniques, with applications in cancer therapeutics and neurodegeneration. The work shows increasing sophistication in membrane protein structural analysis while maintaining direct relevance to disease mechanisms.

Scientific recognition includes:

• Featured as Key Scientific Article in Global Medical Discovery (2014)
• Highlighted in Biophysical Journal's New and Notable section (2014)

Dr. Oh maintains active research funding as evidenced by consistent high-impact publications. His laboratory provides interdisciplinary training in structural biology, biochemistry, and disease mechanism research. Current work focuses on translating structural insights into therapeutic strategies targeting apoptotic pathways in cancer and neurodegenerative conditions.

The Center for Proteomics and Molecular Therapeutics provides advanced instrumentation for structural biology research, including EPR spectroscopy capabilities essential for Dr. Oh's membrane protein studies. Collaborative networks span cancer research centers and neuroscience laboratories, facilitating translational applications of basic mechanism discoveries.